1 / 80

Human Immunodeficiency Virus ( HIV)

Human Immunodeficiency Virus ( HIV). DR VIDYA PAI. HIV. H uman I mmunodeficiency V irus H = Infects only H uman beings I = I mmunodeficiency virus weakens the immune system and increases the risk of infection

britain
Download Presentation

Human Immunodeficiency Virus ( HIV)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Human Immunodeficiency Virus( HIV) DR VIDYA PAI

  2. HIV • Human Immunodeficiency Virus • H = Infects only Human beings • I= Immunodeficiency virus weakens the immune system and increases the risk of infection • V = Virus that attacks the body DR. S.K CHATURVEDI

  3. AIDS • Acquired Immune Deficiency Syndrome • A= Acquired, not inherited • I= Weakens the Immune system • D = Creates a Deficiency of CD4+ cells in the immune system • S= Syndrome, or a group of illnesses taking place at the same time DR. S.K CHATURVEDI

  4. HIV is a lentivirus • genus of the retroviridaefamily • produce multi-organ diseases • characterized by long incubation periods and persistent infection • infect a wide range of prime hosts, as well as some non-primate mammals • Former names of the virus include: • Human T cell lymphotrophic virus (HTLV-III) • Lymphadenopathy associated virus (LAV) • AIDS associated retrovirus (ARV) Courgnaud et al. J. Virol. 75:857, 2001

  5. Two Types of HIV

  6. HIV-1 More virulent Responsible for worldwide epidemic Severity of infection varies from person to person HIV-2 Primarily found in western Africa Not transmitted as efficiently Genome more closely related to SIVmm than HIV-1 HIV-1 vs. HIV-2

  7. HIV-1 likely descended from SIVcpz HIV-2 likely descended from SIVsm Origins of HIV Pan troglodytes troglodytes Sooty Mangabey

  8. Origins of HIV • Researchers claim that these chimps are the source of HIV-1 • Chimps are only rarely infected with SIVcpz • Actual Reservoir maybe a third unidentified primate species • Definite source remains elusive

  9. HIV A Brief History of the modern epidemic

  10. In The Beginning... • 1675 - Speculation that HIV was first transmitted from chimpanzees to humans • 1926-1946 - Scientists believe HIV first spread from monkeys to humans • 1959 - First proven AIDS death • 1978 - Gay men in US and Sweden begin showing signs of what is now known as AIDS ?

  11. 1981 - CDC notices increase in cases of Kaposi’s sarcoma and Pneumocystis carinii pneumonia The First Indications

  12. Defining The Problem • 1982 - The term AIDS (acquired immune deficiency syndrome) is used for the 1st time • 1983 – Luc Monteneier, Institut Pasteur isolates HIV-1, CDC issues warning to blood banks about potential problem • 1984 - Dr. Robert Gallo claims discovery of HIV

  13. The Start of the War • 1985 - FDA approves first HIV antibody diagnostic test - First International Conference on AIDS • 1986 - HIV-2 isolated • 1987 - AZT approved by FDA (1st anti- HIV drug)

  14. Reality Sets In • 1987 - President Reagan says “AIDS” in public - AIDS memorial quilt started

  15. The War Against HIV/AIDS • 1988 - FDA begins granting pre- approval distribution status to HIV/AIDS related drugs • 1989 - First licensed HIV-1 diagnostic kit to directly detect virus (rather than antibodies)

  16. Fighting a Losing Battle? • 1991 - 10 million people worldwide are HIV-positive - Magic Johnson publicly announces he is HIV positive

  17. Increasing The Arsenal • 1992 - FDA starts “accelerated approval” process for HIV/AIDS related drugs • 1995 - Saquinavir (Invirase) is first protease inhibitor approved in US - US admits that Institut Pasteur, not Dr. Gallo, discovered HIV • 1996 - Nevirapine (Viramune) first non- nucleoside reverse transcriptase inhibitor approved in US

  18. Transmission • Unprotected sex • Vagina, Penis, Anal, Oral • Shared needles • Drugs, Steroids, Tattoo, Piercing • Mother to child • Birth, Breast Feeding • Blood transfusions

  19. Transmission

  20. HIV vs. AIDS • HIV causes AIDS by attacking the immune system’s CD4 T cells. • Normal CD4 count is between 500 – 1500 CD4 T cells per ul of blood, while AIDS CD4 count is less than 200 CD4 T cells per ul of blood. • AIDS viral load is about 55,000 HIV RNA copies per ml of blood. • On average, it takes approximately 10 years to develop AIDS from initial infection. • As a person’s CD4 count decreases, he/she is more prone to opportunistic infections.

  21. Characteristics of the virus • Icosahedral (20 sided), enveloped virus of the lentivirus subfamily of retroviruses. • Retroviruses transcribe RNA to DNA. • Two viral strands of RNA found in core surrounded by protein outer coat. • Outer envelope contains a lipid matrix within which specific viral glycoproteins are imbedded. • These knob-like structures responsible for binding to target cell.

  22. Characteristics of the virus • An RNA retrovirus – subfamilyLentivirus • Contains: • 2 copies of RNA • Enzymes: • Reverse Transcriptase • Integrase • Protease • Two major envelope proteins: • gp120 • gp41

  23. Structural Genes • Three main structural genes: • Group Specific Antigen (Gag) • Envelope (Env) • Polymerase (Pol)

  24. Group Specific Antigen (Gag) • Located in nucelocapsid of virus. • Icosahedrylcapsid surrounds the internal nucleic acids made up of p24 andp15. • p17lies between protein core and envelope and is embedded in the internal portion of the envelope. • Two additional p55 products, p7 and p9, are nucleic acid binding proteins closely associated with the RNA.

  25. Envelope (Env) • Envelope (Env) gene codes for envelope proteins gp160, gp120 and gp41. • These polyproteins will eventually be cleaved by proteases to become HIV envelope glycoproteins gp120 and gp41. • gp160 cleaved to form gp120 and gp41. • gp120 forms the 72 knobs which protrude from outer envelope. • gp41 is a transmembrane glycoprotein antigen that spans the inner and outer membranes and attaches to gp120. • gp120 and gp41 both involved with fusion and attachment of HIV to CD4 antigen on host cells.

  26. Polymerase (Pol) • Polymerase (Pol) codes for p66 and p51 subunits of reverse transcriptase and p31 an endonuclease. • Located in the core, close to nucleic acids. • Responsible for conversion of viral RNA into DNA, integration of DNA into host cell DNA and cleavage of protein precursors.

  27. Viral Replication • First step, HIV attaches to susceptible host cell. • Site of attachment is the CD4 antigen found on a variety of cells • helper T cells • macrophages • monocytes • B cells • microglial brain cells • intestinal cells • T cells infected later on.

  28. Early Phase HIV Infection • In early phase HIV infection, initial viruses are M-tropic. Their envelope glycoprotein gp120 is able to bind to CD4 molecules and chemokine receptors called CCR5 found on macrophages

  29. http://www.cat.cc.md.us/courses/bio141/lecguide/unit2/viruses/hivad.htmlhttp://www.cat.cc.md.us/courses/bio141/lecguide/unit2/viruses/hivad.html • In late phase HIV infection, most of the viruses are T-tropic, having gp120 capable of binding to CD4 and CXCR4 found on T4-lymphocytes.

  30. Life Cycle

  31. Viral Replication • The gp120 protein on virus binds specifically to CD4 receptor on host cell with high affinity. • Gp41 causes fusion of the virus to the cell membrane. • After fusion virus particle enters cell. • Viral genome exposed by uncoating particle.

  32. Viral Replication • Reverse transcriptase produces viral DNA from RNA. • Becomes a provirus which integrates into host DNA. • Period of latency occurs. • http://www.cat.cc.md.us/courses/bio141/lecguide/unit2/viruses/hivdsdna.html

  33. Viral Replication • After a period of latency lasting up to 10 years viral replication is triggered and occurs at high rate. • CD4 cell may be destroyed in the process, body attempts to replace lost CD4 cells, but over the course of many years body is unable to keep the count at a safe level. • Destruction of large numbers of CD4 cause symptoms of HIV to appear with increased susceptibility to opportunistic infections, disease and malignancy.

  34. HIV (arrows) Infecting a T-lymphocyte • CD4+ T Cells then chronically die from: • Chronic activation of T cells • Inhibition of thymic output of T cells • Suppression of the bone marrow • Destruction of lymph-node architecture • Low-level ongoing infection of memory CD4+ T cells

  35. Primary HIV Syndrome • Mononucleosis-like, cold or flu-like symptoms may occur 6 to 12 weeks after infection. • lymphadenopathy • fever • rash • headache • Fatigue • diarrhea • sore throat • neurologic manifestations. • no symptoms may be present

  36. Primary HIV Syndrome • Symptoms are relatively nonspecific. • HIV antibody test often negative but becomes positive within 3 to 6 months, this process is known as seroconversion. • Large amount of HIV in the peripheral blood. • Primary HIV can be diagnosed using viral load titer assay or other tests. • Primary HIV syndrome resolves itself and HIV infected person remains asymptomatic for a prolonged period of time, often years.

  37. Clinical Latency Period • HIV continues to reproduce, CD4 count gradually declines from its normal value of 500-1200. • Once CD4 count drops below 500, HIV infected person at risk for opportunistic infections. • The following diseases are predictive of the progression to AIDS: • persistent herpes-zoster infection (shingles) • oral candidiasis (thrush) • oral hairy leukoplakia • Kaposi’s sarcoma (KS)

  38. Oral Candidiasis (thrush)

  39. Oral Hairy Leukoplakia • Being that HIV reduces immunologic activity, the intraoral environment is a prime target for chronic secondary infections and inflammatory processes, including OHL, which is due to the Epstein-Barr virus under immunosuppressed conditions

  40. Kaposi’s sarcoma (KS) • Kaposi’s sarcoma (shown) is a rare cancer of the blood vessels that is associated with HIV. It manifests as bluish-red oval-shaped patches that may eventually become thickened. Lesions may appear singly or in clusters.

  41. Kaposi’s Sarcoma

  42. Bacillary Angiomatosis • Caused by Bartonella species

  43. Herpes Zoster • “Shingles” • Caused by Varicella

  44. AIDS • CD4 count drops below 200 person is considered to have advanced HIV disease • If preventative medications not started the HIV infected person is now at risk for: • Pneumocystis carinii pneumonia (PCP) • cryptococcal meningitis • toxoplasmosis • If CD4 count drops below 50: • Mycobacterium avium • Cytomegalovirus infections • lymphoma • dementia • Most deaths occur with CD4 counts below 50.

  45. Other Opportunistic Infections • Respiratory system • PneumocystisCarinii Pneumonia (PCP) • Tuberculosis (TB) • Kaposi's Sarcoma (KS) • Gastro-intestinal system • Cryptosporidiosis • Candida • Cytomegolavirus (CMV) • Isosporiasis • Kaposi's Sarcoma • Central/peripheral Nervous system • Cytomegolavirus • Toxoplasmosis • Cryptococcosis • Non Hodgkin's lymphoma • Varicella Zoster • Herpes simplex • Skin • Herpes simple • Kaposi's sarcoma • Varicella Zoster

  46. Infants with HIV • Failure to thrive • Persistent oral candidiasis • Hepatosplenomegaly • Lymphadenopathy • Recurrent diarrhea • Recurrent bacterial infections • Abnormal neurologic findings.

  47. Immunologic Manifestations • Early stage slight depression of CD4 count, few symptoms, temporary. • Window of up to 6 weeks before antibody is detected, by 6 months 95% positive. • During window p24 antigen present, acute viremia and antigenemia.

  48. Immunologic Manifestations • Antibodies produced to all major antigens. • First antibodies detected produced against gag proteins p24 and p55. • Followed by antibody to p51, p120 and gp41 • As disease progresses antibody levels decrease.

  49. Immunologic Manifestations • Immune abnormalities associated with increased viral replication. • Decrease in CD4 cells due to virus budding from cells, fusion of uninfected cells with virally infected cells and apoptosis. • B cells have decreased response to antigens possibly due to blockage of T cell/B cell interaction by binding of viral proteins to CD4 site. • CD8 cells initially increase and may remain elevated. • As HIV infection progresses, CD4 T cells drop resulting in immunosuppression and susceptibility of patient to opportunistic infections. • Death comes due to immuno-incompetence.

  50. Immunologic Manifestations • Immune abnormalities associated with increased viral replication. • Decrease in CD4 cells due to virus budding from cells, fusion of uninfected cells with virally infected cells and apoptosis. • B cells have decreased response to antigens possibly due to blockage of T cell/B cell interaction by binding of viral proteins to CD4 site. • CD8 cells initially increase and may remain elevated. • As HIV infection progresses, CD4 T cells drop resulting in immunosuppression and susceptibility of patient to opportunistic infections. • Death comes due to immuno-incompetence.

More Related